Study: NCT04795479

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relacorilant
Description: Relacorilant 400 mg (therapeutic dose) or 800 mg (supra-therapeutic dose) capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relacorilant
Description: Relacorilant 400 mg (therapeutic dose) or 800 mg (supra-therapeutic dose) capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relacorilant
Description: Relacorilant 400 mg (therapeutic dose) or 800 mg (supra-therapeutic dose) capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relacorilant
Description: Relacorilant 400 mg (therapeutic dose) or 800 mg (supra-therapeutic dose) capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relacorilant
Description: Relacorilant 400 mg (therapeutic dose) or 800 mg (supra-therapeutic dose) capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relacorilant
Description: Relacorilant 400 mg (therapeutic dose) or 800 mg (supra-therapeutic dose) capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relacorilant
Description: Relacorilant 400 mg (therapeutic dose) or 800 mg (supra-therapeutic dose) capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relacorilant
Description: Relacorilant 400 mg (therapeutic dose) or 800 mg (supra-therapeutic dose) capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relacorilant
Description: Relacorilant 400 mg (therapeutic dose) or 800 mg (supra-therapeutic dose) capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relacorilant
Description: Relacorilant 400 mg (therapeutic dose) or 800 mg (supra-therapeutic dose) capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relacorilant
Description: Relacorilant 400 mg (therapeutic dose) or 800 mg (supra-therapeutic dose) capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relacorilant
Description: Relacorilant 400 mg (therapeutic dose) or 800 mg (supra-therapeutic dose) capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to relacorilant
Description: Placebo to relacorilant capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to relacorilant
Description: Placebo to relacorilant capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to relacorilant
Description: Placebo to relacorilant capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to relacorilant
Description: Placebo to relacorilant capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to relacorilant
Description: Placebo to relacorilant capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to relacorilant
Description: Placebo to relacorilant capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to relacorilant
Description: Placebo to relacorilant capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to relacorilant
Description: Placebo to relacorilant capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to relacorilant
Description: Placebo to relacorilant capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to relacorilant
Description: Placebo to relacorilant capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to relacorilant
Description: Placebo to relacorilant capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to relacorilant
Description: Placebo to relacorilant capsule by mouth once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Moxifloxacin 400 mg tablet by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Moxifloxacin 400 mg tablet by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Moxifloxacin 400 mg tablet by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Moxifloxacin 400 mg tablet by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Moxifloxacin 400 mg tablet by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Moxifloxacin 400 mg tablet by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Moxifloxacin 400 mg tablet by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Moxifloxacin 400 mg tablet by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Moxifloxacin 400 mg tablet by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Moxifloxacin 400 mg tablet by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Moxifloxacin 400 mg tablet by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Moxifloxacin 400 mg tablet by mouth